Saint Louis, MO · Founded 2011 · Privately Held (backing)
Developer of fluorescent tracer-agent-based systems designed to help provide a vital and actionable measurement of organ function. MediBeacon is based in Saint Louis, MO and was founded in 2011. Its last reported valuation was $300 million in Sep 2019. It has raised $111 million across 10 recorded rounds; the latest was a $16.1 million early-stage round in Aug 2023.
Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$110.6M
Last round
Early Stage VC
Aug 2023
No prints on record
No secondary trades in MediBeacon shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MediBeacon with a free account
·The complete investor list: 16 names
·Watch MediBeacon: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of MediBeacon stock.
